{"nct_id":"NCT01905215","title":"Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines","status":"COMPLETED","status_verified_date":"2017-05","start_date":"2013-07-22","start_date_type":"ACTUAL","primary_completion_date":"2014-04-09","primary_completion_date_type":"ACTUAL","completion_date":"2015-03-16","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}